ArticleFrontiers in medicine2022

A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis.

Zhou Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.